Andrew Burleson
Orthopaedic Surgery · Miamisburg, OHNPI 1851667489
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,700 of the $14,430 with a category attached, or 67.2%. Stryker accounts for 84.0% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $7,635, 3.1 times the $2,435 reported in 2019.
Across 39 payments — averaging $369.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$12K
- Smith+Nephew$1K
- Legacy Ortho LLC$775
- Arthrex$214
- Zimmer Biomet$181
- Biotissue Holdings Inc.$44
- plus $61 from 3 others
What the payments were for
- Consulting fees$9,70067%
- Travel & lodging$3,15522%
- Food & beverage$1,55411%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 23 | $12,126 |
| Smith+Nephew | 3 | $1,028 |
| Legacy Ortho LLC | 4 | $775 |
| Arthrex | 3 | $214 |
| Zimmer Biomet | 2 | $181 |
| Biotissue Holdings Inc. | 1 | $44 |
| Medartis Inc. | 1 | $27 |
| Vericel Corporation | 1 | $21 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALPHAVENT$7,449
- OMEGA$2,000
- Regeneten$900
- HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET$636
- CINCHLOCK SS$607
- INSPACE$396
- ICONIX$287
- Affixus$176
- SALVATION$172
- TRIGEN InterTAN$101
- TRIGEN Femoral (FAN/TAN/Meta Nail)$101
- EVOS$101
How this compares
$14,430 in reported general payments places this provider in the 75th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 127 | $3,619 |
| Methylprednisolone | 42 | $249 |
| Cyclobenzaprine Hcl | 19 | $117 |
| Meloxicam | 29 | $28 |
| Tramadol Hcl | 13 | $24 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Miamisburg
- David WelkerMiamisburg$2.8M
- Andrew RazzanoMiamisburg$77K
- Reuben GobezieCleveland$12M
- Gregory BerletWorthington$9.6M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.8M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- Kenneth GreeneCleveland$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.